Phenytoin Sodium Side Effects

8475167-9 | Overdose, Poisoning, Loss Of Consciousness, Cerebral Infarction
on Jun 19, 2012 Male patient from ECUADOR , 82 years of age, was treated with Phenytoin Sodium Cap(View Usage). Patient experienced the following unwanted or unexpected effects: overdose, poisoning (What is poisoning?), loss of consciousness, cerebral infarction. Phenytoin Sodium Cap dosage: 25 Mg. Patient was hospitalized.

8457728-6 | Erythema, Blister, Pain, Hypoaesthesia
Patient was taking Phenytoin Sodium (View Usage). Patient had the following side effects: erythema, blister, pain (What is pain?), hypoaesthesia on Jun 18, 2012 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 190.0 lb, was diagnosed with convulsion and. Phenytoin Sodium dosage: 3 Caps Twice A Day Po.

8455528-4 | Enuresis, Grand Mal Convulsion
Adverse event was reported on Jun 12, 2012 by a Male patient taking Phenytoin Sodium Cap (View Usage) (Dosage: ) was diagnosed with brain injury, convulsion and. Location: UNITED STATES , 56 years of age, weighting 230.0 lb, After Phenytoin Sodium was administered, patient had the following side effects: enuresis, grand mal convulsion. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), DILANTIN (View Dilantin Review and Dilantin Label ), DIOVAN (View Diovan Review and Diovan Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ).

8447699-0 | Loss Of Consciousness, Poisoning
on Jun 12, 2012 Male patient from ECUADOR , 80 years of age, was treated with Phenytoin Sodium Cap (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, poisoning (What is poisoning?). Phenytoin Sodium Cap dosage: 25 Mg.


8438643-0 | Malaise, Convulsion, Asthenia
on Jun 11, 2012 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with convulsion and was treated with Phenytoin Sodium(View Usage). Patient had the following side effects: malaise, convulsion, asthenia. Phenytoin Sodium dosage: 100mg In Morning And 300mg In Afternoon, 2x/day.

8436834-6 | Road Traffic Accident, Loss Of Consciousness, Convulsion
Patient was taking Phenytoin Sodium Cap (View Usage). After Phenytoin Sodium was administered, patient had the following side effects: road traffic accident, loss of consciousness, convulsion on Jun 08, 2012 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 160.0 lb, was diagnosed with convulsion and. Phenytoin Sodium Cap dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

8424959-0 | Metastatic Neoplasm, Altered State Of Consciousness, Headache, Glioblastoma
Adverse event was reported on May 31, 2012 by a Male patient taking Phenytoin Sodium Cap (View Usage) (Dosage: Daily Dose: 250 Mg) was diagnosed with convulsion prophylaxis, headache (What is headache?), gastritis prophylaxis, metastatic neoplasm, iiird nerve paralysis, vomiting, glioblastoma and. Location: JAPAN , 41 years of age, weighting 112.4 lb, Patient experienced the following unwanted or unexpected effects: metastatic neoplasm, altered state of consciousness, headache (What is headache?), glioblastoma. During the same period patient was treated with LOXONIN (Daily Dose: 180 Mg) (View Loxonin Review and Loxonin Label ), MUCOSTA (Daily Dose: 300 Mg) (View Mucosta Review and Mucosta Label ), WAKOBITAL (Daily Dose: 100 Mg) (View Wakobital Review and Wakobital Label ), DECADRON (View Decadron Review and Decadron Label ), METHYLCOBAL (Daily Dose: 1500 Mcg) (View Methylcobal Review and Methylcobal Label ), RAMELTEON (Daily Dose: 0.1 Mg) (View Ramelteon Review and Ramelteon Label ), GLYCEOL (View Glyceol Review and Glyceol Label ). Patient was hospitalized.

8409140-3 | Amylase Increased
on Apr 24, 2012 Female patient from JAPAN , 21 years of age, weighting 110.2 lb, was treated with Phenytoin Sodium (View Usage). Patient had the following side effects: amylase increased. Phenytoin Sodium dosage: Daily Dose: 250 Mg. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), DIPRIVAN (Daily Dose: 500 Ml) (View Diprivan Review and Diprivan Label ).

8394068-8 | Constipation, Swollen Tongue, Somnolence, Feeling Abnormal, Dysarthria, Vision Blurred
on May 21, 2012 Male patient from UNITED STATES , weighting 175.0 lb, was diagnosed with convulsion and was treated with Phenytoin Sodium(View Usage). After Phenytoin Sodium was administered, patient had the following side effects: constipation (What is constipation?), swollen tongue, somnolence, feeling abnormal, dysarthria, vision blurred. Phenytoin Sodium dosage: Unk. During the same period patient was treated with DILANTIN ((three Capsules Of 100mg In The Morning And Two Capsule Of 100mg In The Evening)) (View Dilantin Review and Dilantin Label ), PRIMIDONE (250 Mg, 2x/day) (View Primidone Review and Primidone Label ).

8390783-0 | Corneal Deposits
Patient was taking Phenytoin Sodium (View Usage). Patient experienced the following unwanted or unexpected effects: corneal deposits on May 24, 2012 from UNITED KINGDOM Additional patient health information: Female patient , 59 years of age, . Phenytoin Sodium dosage: .

8357895-9 | Convulsion, Road Traffic Accident, Loss Of Consciousness
Adverse event was reported on May 04, 2012 by a Male patient taking Phenytoin Sodium Cap (View Usage) (Dosage: ) was diagnosed with convulsion and. Location: UNITED STATES , 67 years of age, weighting 160.0 lb, Patient had the following side effects: convulsion, road traffic accident, loss of consciousness. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

8345490-7 | Urinary Tract Infection, Candidiasis, Stevens-johnson Syndrome
on May 03, 2012 Female patient from PERU , 76 years of age, weighting 88.18 lb, was diagnosed with convulsion and was treated with Phenytoin Sodium Cap (View Usage). After Phenytoin Sodium was administered, patient had the following side effects: urinary tract infection (What is urinary tract infection?), candidiasis, stevens-johnson syndrome. Phenytoin Sodium Cap dosage: 100 Mg, 3x/day. Patient was hospitalized.

8340370-5 | Pyrexia, Burns Second Degree, Rash
on May 02, 2012 Female patient from PERU , 76 years of age, weighting 88.18 lb, was diagnosed with convulsion and was treated with Phenytoin Sodium Cap(View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia, burns second degree, rash (What is rash?). Phenytoin Sodium Cap dosage: 100 Mg, 3x/day. Patient was hospitalized.

8312359-3 | Corneal Deposits
Patient was taking Phenytoin Sodium (View Usage). Patient had the following side effects: corneal deposits on Apr 20, 2012 from UNITED KINGDOM Additional patient health information: Female patient , 60 years of age, . Phenytoin Sodium dosage: .

8301273-5 | Cerebellar Syndrome, Dysarthria
Adverse event was reported on Apr 17, 2012 by a Male patient taking Phenytoin Sodium (View Usage) (Dosage: Dose: 150 Mg Morning And 100 Mg Evening) was diagnosed with epilepsy (What is epilepsy?) and. Location: FRANCE , 74 years of age, After Phenytoin Sodium was administered, patient had the following side effects: cerebellar syndrome, dysarthria. During the same period patient was treated with TEGRETOL (Strength: 400 Mg) (View Tegretol Review and Tegretol Label ), LASIX (View Lasix Review and Lasix Label ), URBANYL (View Urbanyl Review and Urbanyl Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PREVISCAN (View Previscan Review and Previscan Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), CORDARONE (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

8293792-5 | Type 1 Diabetes Mellitus, Alopecia, Diabetic Neuropathy, Epilepsy, Stevens-johnson Syndrome, Renal Failure Chronic, Hypertensive Heart Disease, Pain In Extremity, Anaemia
on Feb 23, 2012 Female patient from UNITED STATES , 50 years of age, weighting 209.0 lb, was diagnosed with convulsion and was treated with Phenytoin Sodium (View Usage). Patient experienced the following unwanted or unexpected effects: type 1 diabetes mellitus, alopecia, diabetic neuropathy, epilepsy (What is epilepsy?), stevens-johnson syndrome, renal failure chronic, hypertensive heart disease, pain in extremity, anaemia. Phenytoin Sodium dosage: 4 Capsules A Day, Oral. During the same period patient was treated with ZOSYN (100 Ml/hr, Q12h, Iv) (View Zosyn Review and Zosyn Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

8276366-1 | Anaplastic Astrocytoma, Streptococcus Test Positive, Neoplasm Progression, Pneumonia Bacterial
on Apr 03, 2012 Female patient from JAPAN , 71 years of age, weighting 110.2 lb, was diagnosed with anaplastic astrocytoma and was treated with Phenytoin Sodium Cap(View Usage). Patient had the following side effects: anaplastic astrocytoma, streptococcus test positive, neoplasm progression, pneumonia bacterial. Phenytoin Sodium Cap dosage: . During the same period patient was treated with KYTRIL /01178102/ (View Kytril /01178102/ Review and Kytril /01178102/ Label ), TEMODAL (Po, 135 Mg/m2;qd;iv, 135 Mg/m2:qd:iv 150 Mg/m2;qd;iv) (View Temodal Review and Temodal Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), NIVADIL (View Nivadil Review and Nivadil Label ).

8274661-3 | White Blood Cell Count Increased, Pyrexia, Hepatic Function Abnormal, Purpura, Hypophagia, Rash, Rash Pustular, Decreased Appetite
Patient was taking Phenytoin Sodium Cap (View Usage). After Phenytoin Sodium was administered, patient had the following side effects: white blood cell count increased, pyrexia, hepatic function abnormal, purpura, hypophagia, rash (What is rash?), rash pustular, decreased appetite on Apr 02, 2012 from JAPAN Additional patient health information: Male patient , 61 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Phenytoin Sodium Cap dosage: . During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), TEGRETOL (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

8273150-X | Respiratory Failure
Adverse event was reported on Apr 04, 2012 by a Male patient taking Phenytoin Sodium Cap (View Usage) (Dosage: Daily Dose: 200 Mg) was diagnosed with simple partial seizures and. Location: JAPAN , 78 years of age, Patient experienced the following unwanted or unexpected effects: respiratory failure. During the same period patient was treated with KEPPRA (After Meal) (View Keppra Review and Keppra Label ).

8270895-2 | Rash Maculo-papular, Systemic Lupus Erythematosus, Pyrexia, Convulsion, Staphylococcus Test Positive
on Apr 10, 2012 Female patient from UNITED STATES , weighting 235.9 lb, was treated with Phenytoin Sodium (View Usage). Patient had the following side effects: rash maculo-papular, systemic lupus erythematosus, pyrexia, convulsion, staphylococcus test positive. Phenytoin Sodium dosage: 200.0 Mg. Patient was hospitalized.

8269735-7 | Sinusitis, Renal Cyst, Pyrexia, Renal Failure, Product Substitution Issue, Dehydration, Chills, Pain
on Mar 23, 2012 Male patient from UNITED STATES , 75 years of age, weighting 180.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Phenytoin Sodium(View Usage). After Phenytoin Sodium was administered, patient had the following side effects: sinusitis (What is sinusitis?), renal cyst, pyrexia, renal failure, product substitution issue, dehydration, chills, pain (What is pain?). Phenytoin Sodium dosage: 100 Mg; Tid; Po. During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ), DIOVAN (View Diovan Review and Diovan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

8262408-6 | Coronary Artery Disease, Toxicity To Various Agents, Electrocardiogram Abnormal, Electrocardiogram St Segment Depression, Electrocardiogram St Segment Elevation, Haemodynamic Instability, Cardiotoxicity, Cardiac Hypertrophy
Patient was taking Phenytoin Sodium (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery disease (What is coronary artery disease?), toxicity to various agents, electrocardiogram abnormal, electrocardiogram st segment depression, electrocardiogram st segment elevation, haemodynamic instability, cardiotoxicity, cardiac hypertrophy on Mar 29, 2012 from ITALY Additional patient health information: Male patient , 53 years of age, was diagnosed with status epilepticus and. Phenytoin Sodium dosage: . During the same period patient was treated with VALPROIC ACID (Unk) (View Valproic Acid Review and Valproic Acid Label ).

8238510-1 | Nephritis, Erythema Multiforme, Hepatitis Acute
Adverse event was reported on Mar 14, 2012 by a Male patient taking Phenytoin Sodium Cap (View Usage) (Dosage: Daily Dose: 200 Mg) was diagnosed with epilepsy (What is epilepsy?) and. Location: JAPAN , 30 years of age, Patient had the following side effects: nephritis, erythema multiforme, hepatitis acute. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), TEGRETOL (Daily Dose: 400 Mg) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

8236919-3 |
on Mar 19, 2012 Male patient from JAPAN , 78 years of age, was diagnosed with simple partial seizures and was treated with Phenytoin Sodium Cap (View Usage). . Phenytoin Sodium Cap dosage: Daily Dose: 200 Mg. During the same period patient was treated with KEPPRA (After Meal) (View Keppra Review and Keppra Label ).

8234412-5 | Loss Of Consciousness
on Mar 21, 2012 Female patient from JAPAN , 58 years of age, weighting 125.7 lb, was diagnosed with epilepsy (What is epilepsy?), pneumonia (What is pneumonia?), prophylaxis and was treated with Phenytoin Sodium Cap(View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness. Phenytoin Sodium Cap dosage: 300 Mg, Daily. During the same period patient was treated with FAMOTIDINE (20 Mg, Daily) (View Famotidine Review and Famotidine Label ), BROTIZOLAM (0.25 Mg, Daily) (View Brotizolam Review and Brotizolam Label ), ZOSYN (4.5 G, 3x/day) (View Zosyn Review and Zosyn Label ), CARBOCAIN (50 Mg, Daily) (View Carbocain Review and Carbocain Label ).

8228205-2 | Pancreatic Enzymes Increased
Patient was taking Phenytoin Sodium (View Usage). Patient had the following side effects: pancreatic enzymes increased on Mar 15, 2012 from JAPAN Additional patient health information: Female patient , 21 years of age, weighting 110.2 lb, . Phenytoin Sodium dosage: Daily Dose: 250 Mg. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), DIPRIVAN (Daily Dose: 500 Ml) (View Diprivan Review and Diprivan Label ).

8219406-8 | Cardiac Arrest
Adverse event was reported on Mar 18, 2012 by a Female patient taking Phenytoin Sodium (View Usage) (Dosage: 150 Mg, 3x/day) was diagnosed with postoperative care and. Location: EGYPT , 68 years of age, After Phenytoin Sodium was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?).

8216100-4 | Convulsion, Amnesia, Product Substitution Issue, Communication Disorder, Vomiting
on Feb 23, 2012 Female patient from UNITED STATES , 66 years of age, weighting 150.0 lb, was diagnosed with convulsion and was treated with Phenytoin Sodium (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, amnesia, product substitution issue, communication disorder, vomiting. Phenytoin Sodium dosage: 200 Mg;qd. During the same period patient was treated with VITAMIN D (View Vitamin D Review and Vitamin D Label ).

8202630-8 |
on Mar 08, 2012 Female patient from EGYPT , 68 years of age, was diagnosed with postoperative care and was treated with Phenytoin Sodium(View Usage). . Phenytoin Sodium dosage: 150 Mg, 3x/day.

8200251-4 | Dry Mouth, Pollakiuria
Patient was taking Phenytoin Sodium (View Usage). After Phenytoin Sodium was administered, patient had the following side effects: dry mouth, pollakiuria on Mar 09, 2012 from UNITED STATES Additional patient health information: Male patient , weighting 173.0 lb, was diagnosed with epilepsy (What is epilepsy?), convulsion, brain injury and. Phenytoin Sodium dosage: 100 Mg Ext Cap. 3 - B/f Bed -} 300mg Total.

8193795-5 | Pancreatic Enzymes Increased
Adverse event was reported on Feb 29, 2012 by a Female patient taking Phenytoin Sodium (View Usage) (Dosage: Daily Dose: 250 Mg) . Location: JAPAN , 21 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: pancreatic enzymes increased. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), DIPRIVAN (Daily Dose: 500 Ml) (View Diprivan Review and Diprivan Label ).

8179108-3 | Balance Disorder, Diplopia, Tremor, Toxicity To Various Agents, Vomiting
on Feb 17, 2012 Female patient from DENMARK , 67 years of age, was diagnosed with epilepsy (What is epilepsy?), depression (What is depression?), prophylaxis against gastrointestinal ulcer and was treated with Phenytoin Sodium (View Usage). Patient had the following side effects: balance disorder, diplopia, tremor, toxicity to various agents, vomiting. Phenytoin Sodium dosage: 400 Mg (400 Mg, 1 In 1 D), Oral. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg (20 Mg, 1 In 1 D), Oral) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), OMEPRAZOLE (20 Mg (10 Mg, 1 In 1 D), Oral) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

8177312-1 | Hypotension, Heart Rate Decreased
on Feb 26, 2012 Female patient from ITALY , 73 years of age, was diagnosed with convulsion and was treated with Phenytoin Sodium(View Usage). After Phenytoin Sodium was administered, patient had the following side effects: hypotension, heart rate decreased. Phenytoin Sodium dosage: 250 Mg, Total Dose. During the same period patient was treated with VALIUM (View Valium Review and Valium Label ).

8174431-0 | Respiratory Disorder, Somnolence
Patient was taking Phenytoin Sodium (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory disorder, somnolence on Feb 28, 2012 from UNITED KINGDOM Additional patient health information: Female patient , weighting 22.05 lb, . Phenytoin Sodium dosage: . During the same period patient was treated with ZONEGRAN (60 Mg) (View Zonegran Review and Zonegran Label ). Patient was hospitalized and became disabled.

8170874-X | Nephritis, Hepatitis Acute, Erythema Multiforme
Adverse event was reported on Feb 16, 2012 by a Male patient taking Phenytoin Sodium Cap (View Usage) (Dosage: Daily Dose: 200 Mg) was diagnosed with epilepsy (What is epilepsy?) and. Location: JAPAN , 30 years of age, Patient had the following side effects: nephritis, hepatitis acute, erythema multiforme. During the same period patient was treated with TEGRETOL (Daily Dose: 400 Mg) (View Tegretol Review and Tegretol Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

8164147-9 | Epilepsy, Toxicity To Various Agents, Diplopia, Vomiting, Balance Disorder, Tremor
on Feb 03, 2012 Female patient from DENMARK , 67 years of age, was diagnosed with epilepsy (What is epilepsy?), prophylaxis against gastrointestinal ulcer, depression (What is depression?) and was treated with Phenytoin Sodium (View Usage). After Phenytoin Sodium was administered, patient had the following side effects: epilepsy (What is epilepsy?), toxicity to various agents, diplopia, vomiting, balance disorder, tremor. Phenytoin Sodium dosage: 400 Mg (400 Mg, 1 In 1 D), Oral, 5 Tablets,oral. During the same period patient was treated with TELMISARTAN (TELMISARTAN) (TELMISARTAN) (View Telmisartan (telmisartan) (telmisartan) Review and Telmisartan (telmisartan) (telmisartan) Label ), OMEPRAZOLE (20 Mg (20 Mg, 1 In 1 D),oral) (View Omeprazole Review and Omeprazole Label ), CITALOPRAM HYDROBROMIDE (20 Mg (20 Mg, 1 In 1 D),oral ) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

8158940-6 | Convulsion
on Feb 06, 2012 Male patient from UNITED KINGDOM , 66 years of age, was treated with Phenytoin Sodium(View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Phenytoin Sodium dosage: 475 Mg Milligram(s),.

8158018-1 | Encephalitis, Disease Progression, Purpura, Pallor, Epilepsy, Erythema, Cerebral Atrophy, Status Epilepticus
Patient was taking Phenytoin Sodium Cap (View Usage). Patient had the following side effects: encephalitis (What is encephalitis?), disease progression, purpura, pallor, epilepsy (What is epilepsy?), erythema, cerebral atrophy, status epilepticus on Feb 14, 2012 from JAPAN Additional patient health information: Female patient , 59 years of age, was diagnosed with epilepsy (What is epilepsy?), simple partial seizures and. Phenytoin Sodium Cap dosage: Unk Ukn, Unk. During the same period patient was treated with VALPROIC ACID (Unk Ukn, Unk) (View Valproic Acid Review and Valproic Acid Label ), TEGRETOL (Unk Ukn, Unk) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

8155412-X | Electroencephalogram Abnormal, Toxicity To Various Agents, Diplopia, Balance Disorder, Tremor, Vomiting
Adverse event was reported on Feb 02, 2012 by a Female patient taking Phenytoin Sodium (View Usage) (Dosage: 500 Mg (500 Mg, 1 In 1 D),oral) was diagnosed with epilepsy (What is epilepsy?), prophylaxis against gastrointestinal ulcer, depression (What is depression?) and. Location: DENMARK , 67 years of age, After Phenytoin Sodium was administered, patient had the following side effects: electroencephalogram abnormal, toxicity to various agents, diplopia, balance disorder, tremor, vomiting. During the same period patient was treated with OMEPRAZOLE (20 Mg (20 Mg, 1 In 1 D), Oral) (View Omeprazole Review and Omeprazole Label ), TELMISARTAN (TELMISARTAN) (TELMISARTAN) (View Telmisartan (telmisartan) (telmisartan) Review and Telmisartan (telmisartan) (telmisartan) Label ), CITALOPRAM HYDROBROMIDE (20 Mg (20 Mg, 1 In 1 D), Oral) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

8153596-0 | Vomiting, Convulsion
on Jan 31, 2012 Female patient from UNITED STATES , 66 years of age, weighting 150.0 lb, was diagnosed with convulsion and was treated with Phenytoin Sodium (View Usage). Patient experienced the following unwanted or unexpected effects: vomiting, convulsion. Phenytoin Sodium dosage: 200 Mg; Qd. During the same period patient was treated with VITAMIN D (View Vitamin D Review and Vitamin D Label ).

8129539-2 | Acute Respiratory Distress Syndrome, Pneumonia Aspiration
on Feb 06, 2012 Male patient from JAPAN , 72 years of age, weighting 110.2 lb, was diagnosed with grand mal convulsion and was treated with Phenytoin Sodium Cap(View Usage). Patient had the following side effects: acute respiratory distress syndrome, pneumonia aspiration. Phenytoin Sodium Cap dosage: Total Daily Dose : 2.4 Gm. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ).

8125658-5 | Vomiting, Diplopia, Balance Disorder, Tremor
Patient was taking Phenytoin Sodium (View Usage). After Phenytoin Sodium was administered, patient had the following side effects: vomiting, diplopia, balance disorder, tremor on Jan 24, 2012 from DENMARK Additional patient health information: Female patient , 67 years of age, was diagnosed with epilepsy (What is epilepsy?), depression (What is depression?), prophylaxis against gastrointestinal ulcer and. Phenytoin Sodium dosage: 5 Tablets, Oral. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg (20 Mg, 1 In 1 D), Oral) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), TELMISARTAN (TELMISARTAN) (TELMISARTAN) (View Telmisartan (telmisartan) (telmisartan) Review and Telmisartan (telmisartan) (telmisartan) Label ), OMEPRAZOLE (20 Mg (20 Mg, 1 In 1 D), Oral) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

8123134-7 | Grand Mal Convulsion
Adverse event was reported on Jan 31, 2012 by a Male patient taking Phenytoin Sodium Cap (View Usage) (Dosage: ) was diagnosed with brain injury and. Location: UNITED STATES , weighting 178.0 lb, Patient experienced the following unwanted or unexpected effects: grand mal convulsion.

8122456-3 | Neuroendocrine Carcinoma Of The Skin, Lymphadenopathy
on Jan 20, 2012 Female patient from UNITED STATES , 74 years of age, weighting 145.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Phenytoin Sodium (View Usage). Patient had the following side effects: neuroendocrine carcinoma of the skin, lymphadenopathy. Phenytoin Sodium dosage: 1 Caps 2x/day; Oral. During the same period patient was treated with GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ).

8119810-2 | Affective Disorder, Depression, Agitation, Anxiety, Irritability, Restlessness, Insomnia, Aggression, Abnormal Behaviour
on Feb 06, 2012 Male patient from UNITED STATES , weighting 211.0 lb, was diagnosed with convulsion and was treated with Phenytoin Sodium(View Usage). After Phenytoin Sodium was administered, patient had the following side effects: affective disorder, depression (What is depression?), agitation, anxiety (What is anxiety?), irritability, restlessness, insomnia, aggression, abnormal behaviour. Phenytoin Sodium dosage: 2 In Morning 3 At Night Morning + Night.

8118568-0 | Tremor, Diplopia, Vomiting, Balance Disorder, Electroencephalogram Abnormal
Patient was taking Phenytoin Sodium (View Usage). Patient experienced the following unwanted or unexpected effects: tremor, diplopia, vomiting, balance disorder, electroencephalogram abnormal on Jan 19, 2012 from DENMARK Additional patient health information: Female patient , 67 years of age, was diagnosed with epilepsy (What is epilepsy?), depression (What is depression?), prophylaxis against gastrointestinal ulcer, hypertension and. Phenytoin Sodium dosage: 500 Mg (500 Mg,1 In 1 D),oral. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg (20 Mg,1 In 1 D),oral) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), OMEPRAZOLE (20 Mg (20 Mg,1 In 1 D),oral) (View Omeprazole Review and Omeprazole Label ), TELMISARTAN (20 Mg (20 Mg,1 In 1 D),oral) (View Telmisartan Review and Telmisartan Label ). Patient was hospitalized.

8074311-5 | Gingival Hyperplasia
Adverse event was reported on Jan 17, 2012 by a Female patient taking Phenytoin Sodium Cap (View Usage) (Dosage: ) was diagnosed with convulsion and. Location: UNITED STATES , 26 years of age, Patient had the following side effects: gingival hyperplasia. Patient was hospitalized.

8072472-5 | Hypersensitivity, Cholestasis, Eosinophilia, Rash, Pruritus
on Jan 18, 2012 Female patient from FRANCE , 80 years of age, was treated with Phenytoin Sodium (View Usage). After Phenytoin Sodium was administered, patient had the following side effects: hypersensitivity, cholestasis, eosinophilia, rash (What is rash?), pruritus. Phenytoin Sodium dosage: Unk. During the same period patient was treated with CORDARONE (Unk) (View Cordarone Review and Cordarone Label ), KEPPRA (Unk) (View Keppra Review and Keppra Label ). Patient was hospitalized.

8053072-X | Lymphadenopathy, Product Substitution Issue, Neuroendocrine Carcinoma Of The Skin
on Dec 28, 2011 Female patient from UNITED STATES , 74 years of age, weighting 145.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Phenytoin Sodium(View Usage). Patient experienced the following unwanted or unexpected effects: lymphadenopathy, product substitution issue, neuroendocrine carcinoma of the skin. Phenytoin Sodium dosage: 1 Caps 2x/day; Oral.

8053057-3 | Constipation, Somnolence, Confusional State
Patient was taking Phenytoin Sodium (View Usage). Patient had the following side effects: constipation (What is constipation?), somnolence, confusional state on Jan 07, 2012 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 145.0 lb, was diagnosed with convulsion and. Phenytoin Sodium dosage: 2 To 5 Caps Daily; Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VITAMIN E + CALCIUM (View Vitamin E + Calcium Review and Vitamin E + Calcium Label ).